Allowing Companies

 
News Articles for Allowing Companies top ^
STAMFORD, Conn., Oct.
Sign-up for Patriot National Bancorp Announces Reversal of Valuation Allowance on Deferred Tax Assets investment picks
-Newly Allowed Claims Demonstrate Regulus' Leadership in the microRNA Field- LA JOLLA, Calif.
Sign-up for Regulus Announces Notice of Allowance from U.S. Patent Office Related to microRNA-103/107 Program in Metabolic Disorders investment picks
2014/10/22
-- First Allowed Patent Application Directly Related to SYN-004 in the U.S. -- ROCKVILLE, Md.
Sign-up for Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program investment picks
- Allowed claims will cover the use of NeuVax alone or in combination to prevent recurrence of any breast cancer tumor expressing low-to-intermediate levels of HER2 - Extends patent coverage to three main markets, U.S., EU and now Japan PORTLAND, Ore., Oct.
Sign-up for Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the US Patent and Trademark Office has granted Notices of Allowance for US Patent Applications, Nos.
Sign-up for Epizyme Announces Notices of Allowance for US Patent Applications Covering PRMT5 Inhibitors and Methods of Cancer Treatment with PRMT5 Inhibitors investment picks
WORCESTER, Mass., Sept.
Sign-up for World Energy Solutions Supports 25th RGGI CO2 Allowance Auction investment picks
Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTC Pink: VPLM) is pleased to announce that the US Patent and Trademark Office (USPTO) has allowed a seventh patent application “Intercepting Voice Over IP Communications and Other Data Communications,” Application No.
Sign-up for Voip-Pal.com Inc.’s Lawful Intercept Patent Continuation Becomes Seventh Patent and Receives Notice of Allowance for Issuance as a Patent investment picks
Hudson Technologies, Inc. (NASDAQ: HDSN), announced that on October 16, 2014 the Environmental Protection Agency (EPA) Administrator Gina McCarthy signed the final rule pertaining to allowances for virgin production of HCFCs, primarily R-22, for 2015 through 2019.
Sign-up for Hudson Technologies Reports the EPA’s Issuance of Final Rule on HCFC Allowances for 2015 Through 2019; More Aggressive Final Rule Than the EPA’s Original Preferred Approach investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978777001&sourceType=1 http://media3.marketwire.com/docs/BlackBerry_logo_200.jpg WATERLOO, ONTARIO --
Sign-up for BlackBerry Announces New Identity and Access Solutions Allowing Enterprises to Embrace Mobility and Cloud Services with Confidence investment picks
2014/11/11
EXFO Enhances 40G/100G lab testing capabilities to allow NEMs and carrier labs to fully qualify and test 100G network elements Canada NewsWire Extended multi-stage ODUmuxing and SONET/SDH client mappings now available on the FTB/IQS-85100G Packet Blazer series QUEBEC CITY , Nov.
Sign-up for EXFO Enhances 40G/100G lab testing capabilities to allow NEMs and carrier labs to fully qualify and test 100G network elements investment picks
2014/11/19
TI receiver and transmitter system efficiently charges one- and two-cell battery-powered applications, supports any Qi-compatible 5-W wireless charging system DALLAS , Nov.
Sign-up for Industry's first 10-W wireless power solution allows consumers to charge faster and cooler without plugging in investment picks
CES 9.2 enables service providers to redefine the customer experience across multiple channels, accelerate time to market, optimize and monetize their networks ST.
Sign-up for Amdocs Latest Portfolio Release - CES 9.2 - Allows Service Providers to Differentiate and Succeed in Today's Hyper-Connected World investment picks
WORCESTER, Mass., Dec.
Sign-up for World Energy Solutions Supports 26th RGGI CO2 Allowance Auction investment picks
Amazon.com (AMZN) said Tuesday it's planning to offer a new pricing feature that will allow shoppers to make an offer to buy items at a lower price.
Sign-up for Amazon to offer feature allowing shoppers to negotiate lower prices investment picks
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and Neuromyelitis Optica (NMO), today announced the expansion of its intellectual property portfolio.
Sign-up for Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent investment picks
CIT Group Inc. (NYSE:CIT), a leading provider of commercial lending and leasing services, today reported net income of $515 million, $2.76 per diluted share, for the third quarter of 2014, compared to net income of $200 million, $0.99 per diluted share, for the year-ago quarter.
Sign-up for CIT Reports Third Quarter 2014 Net Income of $515 Million ($2.76) Per Diluted Share; Net Income Includes $375 Million Reversal of the Tax-Related Valuation Allowance investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Allowing Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Allocation Stock Funds  |  Next: Allscripts Healthcare